Literature DB >> 28980074

Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Xiaotong He1, Qiong Wang1, Yaping Wu2, Jiaan Hu2, Dongmiao Wang2, Bin Qi3, Wei Zhang3, Yanling Wang1, Jie Cheng4,5.   

Abstract

OBJECTIVES: The aim of the present study was to comprehensively summarize the epidemiological, clinicopathological characteristics, treatments as well as prognosis of Castleman's disease (CD) identified in the oral maxillofacial and neck region.
MATERIALS AND METHODS: Patients with CD in the oral maxillofacial and neck were retrieved from disease registry at our institution from Jan. 1990 to Dec. 2015. Systematic reviews from both English and Chinese literature were performed to collect the detailed information about the oral maxillofacial and neck CD. The epidemiological, clinicopathological data and treatment outcomes were further statistically analyzed.
RESULTS: Four patients with the oral maxillofacial and neck CD were identified and histologically confirmed as hyaline-vascular type. They underwent surgical excision without recurrence during the follow-up. Systematic literature reviews identified 221 cases from 123 eligible articles which satisfied the inclusion criteria. In 225 patients, most patients were diagnosed as unicentric (207) or hyaline-vascular type (205) of CD and identified in the neck, and treated by surgical resection with good prognosis. In contrast, the minority of patients was multicentric or plasma-cell/mixed type and treated by chemotherapy with inferior outcomes. Kaplan-Meir analyses revealed that both clinical and pathological types were significantly associated with patients' overall survival.
CONCLUSIONS: Although rare, most cases of the oral maxillofacial neck CD are found in adults and classified as unicentric and hyaline-vascular type of CD. Complete surgical excision is preferred with favorable prognosis for unicentric disease, whereas chemotherapy is usually exploited for multicentric disease with inferior outcomes. CLINICAL RELEVANCE: These data provide comprehensive information about the epidemiology, clinicopathological features, treatments, and outcomes of the oral maxillofacial and neck CD.

Entities:  

Keywords:  Angiofollicular lymph node hyperplasia; Castleman’s disease; Head neck tumor; Pathology; Therapy

Mesh:

Year:  2017        PMID: 28980074     DOI: 10.1007/s00784-017-2232-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  107 in total

1.  Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.

Authors:  Noriko Iwaki; Yasuharu Sato; Katsuyoshi Takata; Eisei Kondo; Kyotaro Ohno; Mai Takeuchi; Yorihisa Orita; Shinji Nakao; Tadashi Yoshino
Journal:  J Clin Exp Hematop       Date:  2013

2.  Concomitant Castleman's disease and sarcoidosis.

Authors:  Brenda L Rice; Carol F Farver; Brad Pohlman; Brian B Burkey; Joseph G Parambil
Journal:  Am J Med Sci       Date:  2011-03       Impact factor: 2.378

3.  Parotid Castleman's disease.

Authors:  J Panayiotides; T Tsilalis; N Bollas; A Karameris
Journal:  Cytopathology       Date:  1998-02       Impact factor: 2.073

4.  Castleman's disease and lymphoepithelial cysts of the parotid in childhood.

Authors:  C Santonja; J García-Aroca; P J Colomar
Journal:  Histopathology       Date:  1997-04       Impact factor: 5.087

5.  Castleman disease of the neck: CT and MR imaging findings.

Authors:  Xin-Hua Jiang; Hao-Ming Song; Qing-Yu Liu; Yun Cao; Guo-Hong Li; Wei-Dong Zhang
Journal:  Eur J Radiol       Date:  2014-09-02       Impact factor: 3.528

6.  Ultrasound appearance of parotid Castleman's disease.

Authors:  A T Ahuja; I C Davey; H K Ng; C Metreweli
Journal:  J Clin Ultrasound       Date:  1995-05       Impact factor: 0.910

7.  Case report: cervical Castleman's disease shown by CT and MRI.

Authors:  S J Freeman; G H Irvine; D Glew
Journal:  Clin Radiol       Date:  1994-10       Impact factor: 2.350

Review 8.  Castleman disease in the pediatric neck: a literature review.

Authors:  Mindy R Rabinowitz; Jessica Levi; Katrina Conard; Udayan K Shah
Journal:  Otolaryngol Head Neck Surg       Date:  2013-03-04       Impact factor: 3.497

9.  Clinical analysis of Castleman disease (hyaline vascular type) in parotid and neck region.

Authors:  Lai-ping Zhong; Li-zhen Wang; Tong Ji; Yu-hua Hu; Yong-jie Hu; Wei-min Ye; Jun Li; Jian Sun; Han-guang Zhu; Jiang Li; Chen-Ping Zhang
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-12-06

10.  A unique presentation of Epstein-Barr virus-associated Castleman's disease.

Authors:  Heather Gomes; Phillip Huyett; Nora Laver; Richard O Wein
Journal:  Am J Otolaryngol       Date:  2013-02-08       Impact factor: 1.808

View more
  2 in total

1.  A retrospective study of 44 patients with head and neck Castleman's disease.

Authors:  Taiqin Wang; Xiaoqiang Chen; Wei Chen; Liangwen Shi; Jianzhi Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-04       Impact factor: 2.503

2.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.